ReviewPolymers2026
Biopolymer-Nanoparticle Interactions in 3D-Printing for Biomedical Applications: Advantages, Limitations and Future Perspectives.
Review in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review comprehensively examines the incorporation of nanoparticles (NPs) into biopolymers for 3D printing in biomedical applications, integrating material design, processing strategies, and translational considerations within a unified framework. Different types of NPs are analyzed regarding their effects on mechanical reinforcement, rheological modulation, and structural organization of biopolymeric matrices. The discussion covers principal additive manufacturing technologies, including extrusion-based systems such as fused deposition modeling (FDM) and direct ink writing (DIW), vat photopolymerization, powder-bed fusion (SLS), and emerging in situ nanoparticle formation approaches, emphasizing how nanoparticle loading and surface functionalization govern yield stress, shear-thinning behavior, viscoelastic recovery, and dimensional fidelity while mitigating agglomeration and optimizing interfacial interactions. Comparative evaluation of compressive modulus, strength, toughness, crystallinity, and porosity establishes structure-property-processing relationships directly linked to printability and functional performance. Biomedical applications are addressed in tissue engineering, biosensing, controlled and targeted drug delivery, and bioimaging, highlighting the balance between bioactivity and manufacturability. Finally, critical challenges-including compatibility, reproducibility, biological safety, long-term stability, regulatory adaptation, and environmental impact-are discussed, alongside future perspectives focused on green nanomaterials, AI-driven predictive formulation design, and digital twins for real-time monitoring and quality control in nano-enabled additive manufacturing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.